{
    "Trade/Device Name(s)": [
        "ADVIA Centaur C-peptide (CpS) Master Curve Material (MCM)",
        "ADVIA Centaur Insulin (IRI) Master Curve Material (MCM)"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K142864",
    "Predicate Device Reference 510(k) Number(s)": [
        "K100810",
        "K101075"
    ],
    "Regulatory Class": "Class I, Reserved",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "September 30, 2014",
    "Summary Letter Received Date": "October 01, 2014",
    "Submission Date": "October 23, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Single (Specified) Analyte Controls (Assayed and Unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "C-peptide",
        "Insulin"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ADVIA Centaur Systems"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material",
        "Master curve material",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Centaur C-peptide and Insulin Master Curve Materials for calibration verification and reportable range checks on ADVIA Centaur systems",
    "Indications for Use Summary": "For in vitro diagnostic use in the verification of calibration and reportable range of the ADVIA Centaur C-peptide and Insulin assays",
    "fda_folder": "Clinical Chemistry"
}